Suppr超能文献

自发性视神经脊髓炎实验性自身免疫性脑脊髓炎小鼠的视网膜病变。

Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis mice.

机构信息

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

出版信息

J Neuroimmunol. 2022 Jun 15;367:577859. doi: 10.1016/j.jneuroim.2022.577859. Epub 2022 Mar 31.

Abstract

Retinal ganglion cells (RGC) are lost as a sequela of optic nerve inflammation in myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD), but the mechanisms of injury remain incompletely understood and there remains a need to characterize the murine model of MOGAD. Several studies have shown that RGC loss occurs in association with optic neuritis in MOG experimental autoimmune encephalomyelitis (EAE), but retinal pathology has not been studied in the double transgenic opticospinal EAE (OSE) model, in which animals develop spontaneous disease associated with MOG peptide specific T cells and B cells producing MOG-specific antibodies. Herein, we show that at 8-weeks OSE mice develop optic nerve inflammation, reactive astrogliosis, and RGC loss. By 10-weeks of age, affected mice have a 50% reduction in RGCs as compared to age matched wild type mice without EAE. The retinal pathology that ensues from spontaneous optic neuritis in OSE mice mirrors that seen following human optic neuritis and may be a useful model for screening neuroprotective compounds for MOGAD and other diseases with optic neuritis.

摘要

视网膜神经节细胞(RGC)在髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)的视神经炎症后继发丢失,但损伤的机制仍不完全清楚,因此仍需要对 MOGAD 的小鼠模型进行特征描述。几项研究表明,在 MOG 实验性自身免疫性脑脊髓炎(EAE)中,视神经炎与 RGC 丢失有关,但在双转基因视神经脊髓炎(OSE)模型中尚未研究视网膜病理学,该模型中动物会发生与 MOG 肽特异性 T 细胞和产生 MOG 特异性抗体的 B 细胞相关的自发性疾病。在此,我们发现 8 周龄的 OSE 小鼠发生视神经炎症、反应性星形胶质细胞增生和 RGC 丢失。到 10 周龄时,与未发生 EAE 的同龄野生型小鼠相比,受影响的小鼠的 RGC 减少了 50%。OSE 小鼠自发性视神经炎引起的视网膜病变与人类视神经炎相似,可能是筛选用于治疗 MOGAD 和其他视神经炎疾病的神经保护化合物的有用模型。

相似文献

本文引用的文献

9
Laquinimod ameliorates secondary brain inflammation.拉喹莫德可改善二级脑炎症。
Neurobiol Dis. 2020 Feb;134:104675. doi: 10.1016/j.nbd.2019.104675. Epub 2019 Nov 13.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验